A new lipid recipe helps mRNA delivery stay on target
Peer-Reviewed Publication
Below are the latest research news from Science China Press.
Updates every hour. Last Updated: 20-Oct-2026 18:16 ET (20-Oct-2026 22:16 GMT/UTC)
Even a local mRNA injection can produce unwanted expression in the liver. Researchers have redesigned the lipid nanoparticles that carry mRNA to reduce this spillover in mice while preserving expression in injected muscle. The formulation also supports repeated dosing and improves the confinement of expression after local brain and eye delivery.
Umbilical cord blood is more than a source of stem cells for transplantation. A review in Science China Life Sciences examines how its diverse cells and bioactive components are being explored for cancer immunotherapy, inherited disorders and tissue repair. The authors connect these opportunities with advances in cell expansion, gene engineering and manufacturing, while identifying barriers to clinical translation. They emphasize that many emerging applications still require further evidence of safety, effectiveness and durable benefit.
A recent study published in National Science Review has revealed silicate magma can store far more oxygen than its chemically allows. In high-pressure experiments, silicate melt can store up to about 5 wt.% excess oxygen, which is released as the magma rising. The findings suggest that oxygen-rich magmas could carry oxidizing power from Earth’s interior toward the surface, and may explain links between large-scale magmatism episodes and atmospheric oxidation in Earth’s history.
A research team from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, has developed a hypoxia-responsive, tumor-penetrating lipoplex that can generate NKG2D CAR-T and NK cells directly within solid tumors. This dual-controlled strategy enables local CAR generation in triple-negative breast cancer via targeting GRM4 and utilizing a hypoxia-inducible promoter, significantly enhancing antitumor immunity while minimizing off-target expression and inflammatory side effects. This study offers a promising precision strategy to engineer CARs in solid tumors with enhanced safety.
The tumor-confined nano-activator (iCLANTSP-SAg) can drive localized expression of bacterial superantigens within tumors, enabling potent, antigen-independent T-cell activation while avoiding systemic toxicity.
Scientists have developed a simple yet powerful strategy to overcome a long-standing challenge in cancer phototheranostics—the trade-off between imaging brightness, therapeutic efficacy, and biological stability. By systematically replacing hydrogen atoms with deuterium (a heavier isotope) in a near-infrared fluorescent molecule, researchers achieved simultaneous improvements in all three critical properties. The optimized nanoparticles delivered 26% higher fluorescence brightness, 14% more reactive oxygen species for killing cancer cells, and 20% better stability in blood. In mouse models, a single treatment completely eliminated breast tumors, and fluorescence-guided surgery enabled precise removal of colorectal cancer remnants that were invisible under white light—extending survival from under 20 days to over 60 days. The strategy is broadly applicable and does not require redesigning the molecular backbone, offering a versatile platform for next-generation cancer theranostics.